Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis
Faizan Khan(University of Ottawa), Marc Rodger(Ottawa Hospital), Timothy Brighton(Prince of Wales Hospital), Mary Cushman, L. Pinède(Infirmerie Protestante), George A. Wells(University of Ottawa), Elham Sabri(Ottawa Hospital), Harry R. Büller(Academic Medical Center), Alvi Rahman(University College London), Sabine Eichinger(Universitätsmedizin Greifswald), Marc Carrier, Paul A. Kyrle(Karl Landsteiner Society), Brian Hutton(University of Ottawa), Cecilia Becattini(University of Perugia), Françis Couturaud(Inserm), Jeffrey I. Weitz(McMaster University), Sam Schulman(Hamilton General Hospital), Giancarlo Agnelli(University of Perugia), Paolo Prandoni, Anthonie W.A. Lensing(Bayer (Germany)), Clive Kearon(McMaster University), Martin H. Prins(Maastricht University), Gualtiero Palareti(Policlinico S.Orsola-Malpighi)
Cited by 312
Related Papers
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
|Circulation|2018|7.2k
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients
|Journal of Thrombosis and Haemostasis|2005|4.9k
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
|Journal of Thrombosis and Haemostasis|2009|3.8k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k